Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout

Aim: To study the differences in cardiovascular risk between type 2 diabetic and non-diabetic patients with asymptomatic hyperuricemia and gout using the Framingham Risk Score (FRS) and complex multimodal ultrasonography.

Guardado en:

Detalles Bibliográficos
Autores principales:	Gancheva R., Kundurdjiev A., Kundurdjiev T., Kolarov Zl.
Formato:	article
Lenguaje:	EN
Publicado:	Sciendo 2019
Materias:	cardiovascular risk type 2 diabetes asymptomatic hyperuricemia tophi Medicine R
Acceso en línea:	https://doaj.org/article/7c70e2637a4f47d7b64054857482709b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7c70e2637a4f47d7b64054857482709b
record_format	dspace
spelling	oai:doaj.org-article:7c70e2637a4f47d7b64054857482709b2021-12-02T17:31:31ZCardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout0324-175010.2478/amb-2019-0012https://doaj.org/article/7c70e2637a4f47d7b64054857482709b2019-05-01T00:00:00Zhttps://doi.org/10.2478/amb-2019-0012https://doaj.org/toc/0324-1750Aim: To study the differences in cardiovascular risk between type 2 diabetic and non-diabetic patients with asymptomatic hyperuricemia and gout using the Framingham Risk Score (FRS) and complex multimodal ultrasonography.Gancheva R.Kundurdjiev A.Kundurdjiev T.Kolarov Zl.Sciendoarticlecardiovascular risktype 2 diabetesasymptomatic hyperuricemiatophiMedicineRENActa Medica Bulgarica, Vol 46, Iss 2, Pp 13-20 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	cardiovascular risk type 2 diabetes asymptomatic hyperuricemia tophi Medicine R
spellingShingle	cardiovascular risk type 2 diabetes asymptomatic hyperuricemia tophi Medicine R Gancheva R. Kundurdjiev A. Kundurdjiev T. Kolarov Zl. Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout
description	Aim: To study the differences in cardiovascular risk between type 2 diabetic and non-diabetic patients with asymptomatic hyperuricemia and gout using the Framingham Risk Score (FRS) and complex multimodal ultrasonography.
format	article
author	Gancheva R. Kundurdjiev A. Kundurdjiev T. Kolarov Zl.
author_facet	Gancheva R. Kundurdjiev A. Kundurdjiev T. Kolarov Zl.
author_sort	Gancheva R.
title	Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout
title_short	Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout
title_full	Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout
title_fullStr	Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout
title_full_unstemmed	Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout
title_sort	cardiovascular risk in type 2 diabetic patients with asymptomatic hyperuricemia and gout
publisher	Sciendo
publishDate	2019
url	https://doaj.org/article/7c70e2637a4f47d7b64054857482709b
work_keys_str_mv	AT ganchevar cardiovascularriskintype2diabeticpatientswithasymptomatichyperuricemiaandgout AT kundurdjieva cardiovascularriskintype2diabeticpatientswithasymptomatichyperuricemiaandgout AT kundurdjievt cardiovascularriskintype2diabeticpatientswithasymptomatichyperuricemiaandgout AT kolarovzl cardiovascularriskintype2diabeticpatientswithasymptomatichyperuricemiaandgout
_version_	1718380562659409920

Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout

Ejemplares similares